Thor Medical completes AlphaOne facility construction
Thor Medical has finished building its AlphaOne facility and begun commissioning, staying on track to start production in the third quarter.
News and press releases
School collaborationVariert, nyttig og spennende hos Sanofi
11 elever fra både andre og tredje klasse på Ullern videregående skole fikk være en hel dag hos det franske legemiddelselskapet Sanofis kontorer i Norge på Lysaker. Ungdommene fikk noen aha-opplevelser om hva det vil si å jobbe i et legemiddelselskap, hva slags regler det finnes på feltet og framtidige jobbmuligheter.
Clinical trialsNew clinical trial against glioblastoma
An innovative cancer treatment from Norway will be tested for the first time on patients with glioblastoma in the US.
CollaborationPartnership for better treatment decisions
A new collaboration aims to bridge the gap between regulatory approval and the real-world information that clinicians and health authorities need to make informed treatment decisions.
CollaborationNew Norwegian collaboration in radiopharmacy against cancer
Thor Medical has entered an agreement with Node Pharma to supply isotopes.
PoliticsClinical trialsVestre: “We will be leading; we will be the best”
A new governmental plan makes bold promises to attract clinical studies to Norway, but will it deliver?
Subscribe to our newsletter
Get monthly news updates and invitations to events from our oncology cluster.
PoliticsDon't spend innovation capital on bricks and mortar
The government wants to focus Siva's activities solely on real estate. This is presented as a technical reorganisation, but in reality it is a political choice about the role the state should play in the development of new industries. We cannot spend innovation capital and expect to become richer.
School collaborationStorkoste seg hos patologen
Fire videregående-elever fra Ullern tilbrakte to dager på patologiavdelingen på Radiumhospitalet. Det skulle vise seg å bli noe av det mest spennende de hadde gjort, og ga dem bekreftelse på videre utdanningsløp.
ResearchPrecision medicineRecord investment strengthens Norway’s childhood cancer research
Oslo Cancer Cluster Incubator based team was awarded NOK 3 450 000 from a record allocation of NOK 45.6 million in research funding announced by the Norwegian Childhood Cancer Society.
EventCancer Crosslinks picture show
Cancer Crosslinks turns 18 years in 2026, making it one of the best-established cancer meeting series in Norway. This is what it looks like.
PoliticsUSA har rett om legemiddelpriser
Kronikk. USA peker, kanskje ufrivillig, på noe viktig: Fremtidens legemiddelutvikling krever at flere bidrar, på flere måter enn bare gjennom pris.
MembersMeet the new members
We are pleased to introduce the newest members of our cluster, Barnekreftforeningen and BearingPoint.
